• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种临床相关多发性硬化症小鼠模型的神经免疫差异模式。

Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis.

机构信息

Department of Neurology, Dartmouth Hitchcock Medical Center and Geisel School of Medicine, One Medical Center Drive, Lebanon, NH, 03756, USA.

Program in Experimental and Molecular Medicine, Dartmouth College, Hanover, NH, USA.

出版信息

J Neuroinflammation. 2019 May 22;16(1):109. doi: 10.1186/s12974-019-1501-9.

DOI:10.1186/s12974-019-1501-9
PMID:31118079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6532235/
Abstract

BACKGROUND

The mechanisms driving multiple sclerosis (MS), the most common cause of non-traumatic disability in young adults, remain unknown despite extensive research. Especially puzzling are the underlying molecular processes behind the two major disease patterns of MS: relapsing-remitting and progressive. The relapsing-remitting course is exemplified by acute inflammatory attacks, whereas progressive MS is characterized by neurodegeneration on a background of mild-moderate inflammation. The molecular and cellular features differentiating the two patterns are still unclear, and the role of inflammation during progressive disease is a subject of active debate.

METHODS

We performed a comprehensive analysis of the intrathecal inflammation in two clinically distinct mouse models of MS: the PLP-induced relapsing experimental autoimmune encephalomyelitis (R-EAE) and the chronic progressive, Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD). Microarray technology was first used to examine global gene expression changes in the spinal cord. Inflammation in the spinal cord was further assessed by immunohistochemical image analysis and flow cytometry. Levels of serum and cerebrospinal fluid (CSF) immunoglobulin (Ig) isotypes and chemokines were quantitated using Luminex Multiplex technology, whereas a capture ELISA was used to measure serum and CSF albumin levels. Finally, an intrathecal Ig synthesis index was established with the ratio of CSF and serum test results corrected as a ratio of their albumin concentrations.

RESULTS

Microarray analysis identified an enrichment of B cell- and Ig-related genes upregulated in TMEV-IDD mice. We also demonstrated an increased level of intrathecal Ig synthesis as well as a marked infiltration of late differentiated B cells, including antibody secreting cells (ASC), in the spinal cord of TMEV-IDD, but not R-EAE mice. An intact blood-brain barrier in TMEV-IDD mice along with higher CSF levels of CXCL13, CXCL12, and CCL19 provides evidence for an intrathecal synthesis of chemokines mediating B cell localization to the central nervous system (CNS).

CONCLUSIONS

Overall, these findings, showing increased concentrations of intrathecally produced Igs, substantial infiltration of ASC, and the presence of B cell supporting chemokines in the CNS of TMEV-IDD mice, but not R-EAE mice, suggest a potentially important role for Igs and ASC in the chronic progressive phase of demyelinating diseases.

摘要

背景

多发性硬化症(MS)是导致年轻人非创伤性残疾的最常见原因,尽管进行了广泛的研究,但仍不清楚其发病机制。特别令人困惑的是 MS 的两种主要疾病模式背后的潜在分子过程:复发缓解型和进行性。复发缓解型疾病以急性炎症发作为例,而进行性 MS 则以轻度中度炎症背景下的神经退行性变为特征。区分这两种模式的分子和细胞特征尚不清楚,炎症在进行性疾病中的作用是一个活跃的争论话题。

方法

我们对两种临床上不同的 MS 小鼠模型(PLP 诱导的复发型实验性自身免疫性脑脊髓炎(R-EAE)和慢性进行性,Theiler 鼠脑脊髓炎病毒诱导的脱髓鞘疾病(TMEV-IDD))的鞘内炎症进行了全面分析。首先使用微阵列技术检查脊髓中的全局基因表达变化。通过免疫组织化学图像分析和流式细胞术进一步评估脊髓炎症。使用 Luminex 多重技术定量测定血清和脑脊液(CSF)免疫球蛋白(Ig)同种型和趋化因子的水平,而捕获 ELISA 用于测量血清和 CSF 白蛋白水平。最后,通过将 CSF 和血清测试结果的比值校正为其白蛋白浓度的比值,建立鞘内 Ig 合成指数。

结果

微阵列分析鉴定出 TMEV-IDD 小鼠中上调的 B 细胞和 Ig 相关基因的富集。我们还证明了 TMEV-IDD 而不是 R-EAE 小鼠脊髓中鞘内 Ig 合成水平升高以及晚期分化 B 细胞(包括抗体分泌细胞(ASC))的明显浸润。TMEV-IDD 小鼠完整的血脑屏障以及更高的 CSF 中 CXCL13、CXCL12 和 CCL19 的水平提供了证据,证明趋化因子在中枢神经系统(CNS)中介导 B 细胞定位的鞘内合成。

结论

总的来说,这些发现表明 TMEV-IDD 小鼠的鞘内产生的 Ig 浓度增加,ASC 大量浸润,以及 CNS 中存在支持 B 细胞的趋化因子,但 R-EAE 小鼠没有,这表明 Ig 和 ASC 在脱髓鞘疾病的慢性进行性阶段可能具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/3254e643b208/12974_2019_1501_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/5b35c7bdf794/12974_2019_1501_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/a65352445aea/12974_2019_1501_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/d0c0a3178bf7/12974_2019_1501_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/861be8acc4d7/12974_2019_1501_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/e81c62e49af0/12974_2019_1501_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/b9bccf5220a3/12974_2019_1501_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/3254e643b208/12974_2019_1501_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/5b35c7bdf794/12974_2019_1501_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/a65352445aea/12974_2019_1501_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/d0c0a3178bf7/12974_2019_1501_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/861be8acc4d7/12974_2019_1501_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/e81c62e49af0/12974_2019_1501_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/b9bccf5220a3/12974_2019_1501_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb53/6532235/3254e643b208/12974_2019_1501_Fig7_HTML.jpg

相似文献

1
Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis.两种临床相关多发性硬化症小鼠模型的神经免疫差异模式。
J Neuroinflammation. 2019 May 22;16(1):109. doi: 10.1186/s12974-019-1501-9.
2
Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis.中枢神经系统炎症聚集体在进行性多发性硬化的 Theiler 病毒模型中。
Front Immunol. 2019 Aug 2;10:1821. doi: 10.3389/fimmu.2019.01821. eCollection 2019.
3
Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.进行性多发性硬化症中报道的脊髓病变与 Theiler 氏鼠脑脊髓炎病毒诱导的脱髓鞘疾病的比较。
Int J Mol Sci. 2019 Feb 25;20(4):989. doi: 10.3390/ijms20040989.
4
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.TIM-3通路可改善泰勒氏鼠脑脊髓炎病毒诱导的脱髓鞘疾病。
Int Immunol. 2014 Jul;26(7):369-81. doi: 10.1093/intimm/dxt056. Epub 2014 Jan 31.
5
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.在泰勒氏病毒诱导的脱髓鞘疾病中,中枢神经系统的免疫反应从早期适应性反应转变为慢性固有样反应。
J Neurovirol. 2016 Feb;22(1):66-79. doi: 10.1007/s13365-015-0369-4. Epub 2015 Aug 11.
6
Divergent complement system activation in two clinically distinct murine models of multiple sclerosis.两种临床上不同的多发性硬化症小鼠模型中补体系统的激活情况存在差异。
Front Immunol. 2022 Jul 26;13:924734. doi: 10.3389/fimmu.2022.924734. eCollection 2022.
7
Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.在两种临床特征不同的多发性硬化模型中,炎性细胞因子的差异表达与中枢神经系统病理进展平行。
J Immunol. 1998 Oct 15;161(8):4437-46.
8
Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.多发性硬化的两种模型:实验性变应性脑脊髓炎(EAE)和泰勒鼠脑脊髓炎病毒(TMEV)感染。病理与免疫学比较。
Microsc Res Tech. 1995 Oct 15;32(3):215-29. doi: 10.1002/jemt.1070320305.
9
Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.多发性硬化症动物模型中中枢神经系统的抗体分泌细胞:表型、与残疾的关联及抗体的体外产生
J Neuroimmunol. 2007 Oct;190(1-2):112-20. doi: 10.1016/j.jneuroim.2007.09.001. Epub 2007 Oct 4.
10
Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.干扰素刺激基因——在抵抗 Theiler 病毒诱导的脱髓鞘疾病中起关键抗病毒作用的效应物。
J Neuroinflammation. 2015 Dec 24;12:242. doi: 10.1186/s12974-015-0462-x.

引用本文的文献

1
B cells are not drivers of stromal cell activation during acute CNS infection.在急性中枢神经系统感染期间,B细胞并非基质细胞激活的驱动因素。
J Neuroinflammation. 2025 Jun 27;22(1):165. doi: 10.1186/s12974-025-03491-7.
2
The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System.小胶质细胞和脑浸润巨噬细胞在 TMEV 感染中枢神经系统时对神经炎症和神经退行性疾病发病机制的贡献。
Viruses. 2024 Jan 13;16(1):119. doi: 10.3390/v16010119.
3
Theiler's virus-induced demyelinating disease as an infectious model of progressive multiple sclerosis.

本文引用的文献

1
The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.多发性硬化症大脑中的分隔性炎症反应由组织驻留的 CD8+ T 淋巴细胞和 B 细胞组成。
Brain. 2018 Jul 1;141(7):2066-2082. doi: 10.1093/brain/awy151.
2
[Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis].[利妥昔单抗:其在治疗多发性硬化症中的疗效、有效性及安全性]
Rev Neurol. 2018 Jan 1;66(1):25-32.
3
The chronically inflamed central nervous system provides niches for long-lived plasma cells.
泰勒氏病毒诱导的脱髓鞘疾病作为进行性多发性硬化症的感染模型。
Front Mol Neurosci. 2022 Oct 13;15:1019799. doi: 10.3389/fnmol.2022.1019799. eCollection 2022.
4
The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy.多发性硬化早期治疗的全新世界:利用分子生物标志物CXCL13和神经丝轻链优化免疫治疗
Biomedicines. 2022 Aug 28;10(9):2099. doi: 10.3390/biomedicines10092099.
5
Divergent complement system activation in two clinically distinct murine models of multiple sclerosis.两种临床上不同的多发性硬化症小鼠模型中补体系统的激活情况存在差异。
Front Immunol. 2022 Jul 26;13:924734. doi: 10.3389/fimmu.2022.924734. eCollection 2022.
6
Comparative Profiling of TG2 and Its Effectors in Human Relapsing Remitting and Progressive Multiple Sclerosis.人复发缓解型和进展型多发性硬化症中TG2及其效应分子的比较分析
Biomedicines. 2022 May 26;10(6):1241. doi: 10.3390/biomedicines10061241.
7
The Neuroimmunology of Multiple Sclerosis: Fictions and Facts.多发性硬化症的神经免疫学:虚构与事实
Front Neurol. 2022 Feb 7;12:796378. doi: 10.3389/fneur.2021.796378. eCollection 2021.
8
Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus-induced demyelination.神经亲和性病毒感染后的转录组分析揭示了易感染病毒诱导脱髓鞘的小鼠固有免疫缺陷和抗原呈递延迟。
Brain Pathol. 2021 Nov;31(6):e13000. doi: 10.1111/bpa.13000. Epub 2021 Jul 6.
9
Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis.多发性硬化症中的记忆 B 细胞:疾病发病机制中的新兴参与者。
Front Immunol. 2021 Jun 8;12:676686. doi: 10.3389/fimmu.2021.676686. eCollection 2021.
慢性炎症的中枢神经系统为长寿浆细胞提供了栖息地。
Acta Neuropathol Commun. 2017 Nov 25;5(1):88. doi: 10.1186/s40478-017-0487-8.
4
Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis.聚乙二醇化干扰素β治疗多发性硬化症的泰勒氏鼠脑脊髓炎病毒小鼠模型
J Neuroimmunol. 2017 Dec 15;313:34-40. doi: 10.1016/j.jneuroim.2017.10.004. Epub 2017 Oct 9.
5
Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.用特立氟胺治疗西尼罗河病毒诱导的脱髓鞘疾病。
J Neurovirol. 2017 Dec;23(6):825-838. doi: 10.1007/s13365-017-0570-8. Epub 2017 Sep 14.
6
Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.鞘内IgM指数与多发性硬化症的严重病程相关:临床和MRI结果
Clin Neurol Neurosurg. 2017 Sep;160:27-29. doi: 10.1016/j.clineuro.2017.05.026. Epub 2017 Jun 1.
7
The Other Function: Class II-Restricted Antigen Presentation by B Cells.其他功能:B细胞的II类限制性抗原呈递
Front Immunol. 2017 Mar 23;8:319. doi: 10.3389/fimmu.2017.00319. eCollection 2017.
8
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.多发性硬化症患者皮质病变负荷增加和鞘内炎症与寡克隆带相关:脑脊液和磁共振成像联合研究
J Neuroinflammation. 2017 Feb 21;14(1):40. doi: 10.1186/s12974-017-0812-y.
9
B cells in multiple sclerosis.多发性硬化症中的B细胞。
Autoimmunity. 2017 Feb;50(1):57-60. doi: 10.1080/08916934.2017.1281914.
10
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.奥瑞珠单抗与安慰剂治疗原发性进行性多发性硬化症。
N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.